News & Updates

Poor glycaemic control tied to COVID-19 progression

30 Jun 2022

High concentrations of glycated haemoglobin (HbA1c) at hospital admission appears to increase the risk of COVID-19 progression to severe disease, a recent study has found.

Poor glycaemic control tied to COVID-19 progression

30 Jun 2022

Persistent ALT elevation triples risk of future T2D among overweight, obese children

30 Jun 2022 by

Children with overweight or obesity risk developing future type 2 diabetes (T2D) by threefold in the presence of persistent elevations in alanine aminotransferases (ALT), according to a study presented at the 54th Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN 2022).

Persistent ALT elevation triples risk of future T2D among overweight, obese children

30 Jun 2022

Thyroidectomy for PTMC: less complications, more recurrence with partial vs total removal

30 Jun 2022 by

In a systematic review and meta-analysis of studies on primary surgical treatment outcomes for individuals with papillary thyroid microcarcinoma (PTMC; ≤1.0 cm at greatest diameter), hemithyroidectomy (HT) was associated with lower risks of postoperative complications but a higher incidence of overall recurrence compared with total thyroidectomy (TT).

Thyroidectomy for PTMC: less complications, more recurrence with partial vs total removal

30 Jun 2022

Antioxidant cocktail works against diabetic polyneuropathy in T2D

30 Jun 2022

Treatment with a combination of succinic acid, inosine, nicotinamide, and riboflavin (SINR) is safe and alleviates the symptoms of diabetic polyneuropathy in patients with type 2 diabetes (T2D), according to data from the CYLINDER study.

Antioxidant cocktail works against diabetic polyneuropathy in T2D

30 Jun 2022

Varenicline helps T2D patients quit smoking

29 Jun 2022 by

Use of varenicline in a smoking cessation program for patients with type 2 diabetes (T2D) is safe and effective, facilitating long-term abstinence without adverse consequences, according to the results of a trial.

Varenicline helps T2D patients quit smoking

29 Jun 2022

Inability to stand on a leg for 10 sec tied to shorter life in older adults

27 Jun 2022 by

Inability to stand on one leg for 10 seconds (sec) is strongly linked to a higher risk of death, and consequently, a shorter life expectancy in older adults, according to a study in Brazil.

Inability to stand on a leg for 10 sec tied to shorter life in older adults

27 Jun 2022

Regular statin use offers protection against diabetes in acute pancreatitis patients

27 Jun 2022

Regular statin users appear to be at lower risk of developing diabetes mellitus following an episode of acute pancreatitis, as shown in a study.

Regular statin use offers protection against diabetes in acute pancreatitis patients

27 Jun 2022

Glargine, degludec improve glycaemic control in patients switching from first-gen insulin

27 Jun 2022

Among type 2 diabetes (T2D) patients on first-generation basal insulins (1BIs), a switch to either glargine or degludec in the real-world setting leads to marked improvements in glucose control without increasing the risk of hypoglycaemic events and weight gain, according to a study. Furthermore, the benefits seem to be comparable between the two second-generation basal insulins (2BIs).

Glargine, degludec improve glycaemic control in patients switching from first-gen insulin

27 Jun 2022

Calorie restriction blunts long-term kidney decline, improves CV risk factors in obese T2D patients

26 Jun 2022

In type 2 diabetes (T2D) patients with obesity, calorie restriction helps correct several cardiovascular (CV) risk factors and glomerular hyperfiltration, with the latter translating into a relative long-term stabilization of kidney function, according to a study.

Calorie restriction blunts long-term kidney decline, improves CV risk factors in obese T2D patients

26 Jun 2022

Tirzepatide: A winning weight-loss therapy for nondiabetic, obese adults

25 Jun 2022 by

Non-diabetic overweight or obese adults experienced a greater reduction in weight and cardiometabolic measures with the addition of tirzepatide to their lifestyle interventions, findings of the SURMOUNT-1 trial showed.

Tirzepatide: A winning weight-loss therapy for nondiabetic, obese adults

25 Jun 2022

News & Updates

Filter by Specialty:

Specialty:

Poor glycaemic control tied to COVID-19 progression

Poor glycaemic control tied to COVID-19 progression

Persistent ALT elevation triples risk of future T2D among overweight, obese children

Persistent ALT elevation triples risk of future T2D among overweight, obese children

Thyroidectomy for PTMC: less complications, more recurrence with partial vs total removal

Thyroidectomy for PTMC: less complications, more recurrence with partial vs total removal

Antioxidant cocktail works against diabetic polyneuropathy in T2D

Antioxidant cocktail works against diabetic polyneuropathy in T2D

Varenicline helps T2D patients quit smoking

Varenicline helps T2D patients quit smoking

Inability to stand on a leg for 10 sec tied to shorter life in older adults

Inability to stand on a leg for 10 sec tied to shorter life in older adults

Regular statin use offers protection against diabetes in acute pancreatitis patients

Regular statin use offers protection against diabetes in acute pancreatitis patients

Glargine, degludec improve glycaemic control in patients switching from first-gen insulin

Glargine, degludec improve glycaemic control in patients switching from first-gen insulin

Calorie restriction blunts long-term kidney decline, improves CV risk factors in obese T2D patients

Calorie restriction blunts long-term kidney decline, improves CV risk factors in obese T2D patients

Tirzepatide: A winning weight-loss therapy for nondiabetic, obese adults

Tirzepatide: A winning weight-loss therapy for nondiabetic, obese adults